Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Vendramini LC, Dalboni MA, de Carvalho JTG Jr, Batista MC, Nishiura JL, Heilberg IP.

Front Med (Lausanne). 2019 May 24;6:112. doi: 10.3389/fmed.2019.00112. eCollection 2019.

2.

Searching for mutations in the HNF1B gene in a Brazilian cohort with renal cysts and hyperglycemia.

Dotto RP, Santana LS, Lindsey SC, Caetano LA, Franco LF, Moisés RCMS, Sa JR, Nishiura JL, Teles MG, Heilberg IP, Dias-da-Silva MR, Giuffrida FMA, Reis AF.

Arch Endocrinol Metab. 2019 May-Jun;63(3):250-257. doi: 10.20945/2359-3997000000138. Epub 2019 May 2.

3.

Exercise capacity in polycystic kidney disease.

Reinecke NL, Cunha TM, Heilberg IP, Higa EM, Nishiura JL, Neder JA, Almeida WS, Schor N.

Am J Kidney Dis. 2014 Aug;64(2):239-46. doi: 10.1053/j.ajkd.2014.03.014. Epub 2014 Apr 29.

PMID:
24787761
4.

Pain determinants of pain in autosomal dominant polycystic kidney disease.

Nishiura JL, Eloi SR, Heilberg IP.

J Bras Nefrol. 2013 Jul-Sep;35(3):242-3. doi: 10.5935/0101-2800.20130038.

5.

Caffeine intake by patients with autosomal dominant polycystic kidney disease.

Vendramini LC, Nishiura JL, Baxmann AC, Heilberg IP.

Braz J Med Biol Res. 2012 Sep;45(9):834-40. Epub 2012 Jul 19.

6.

Anxiety, depression, and quality of life in patients with familial glomerulonephritis or autosomal dominant polycystic kidney disease.

de Barros BP, Nishiura JL, Heilberg IP, Kirsztajn GM.

J Bras Nefrol. 2011 Apr-Jun;33(2):120-8. English, Portuguese.

7.

Translation, cultural adaptation and aplication of a pain questionnaire for patients with polycystic kidney disease.

Eloi SR, Nishiura JL, Heilberg IP.

J Bras Nefrol. 2010 Dec;32(4):386-99. English, Portuguese.

8.

How to avoid discontinuation of antihypertensive treatment: The experience in São Paulo, Brazil.

Ortega KC, Gusmão JL, Pierin AM, Nishiura JL, Ignez EC, Segre CA, Ventura CG, Mano GP, Fontes V, Cunha FM, Mion D Jr.

Clinics (Sao Paulo). 2010;65(9):857-63.

9.

Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP.

Clin J Am Soc Nephrol. 2009 Apr;4(4):838-44. doi: 10.2215/CJN.03100608. Epub 2009 Apr 1.

10.

Preservation of urine samples for metabolic evaluation of stone-forming patients.

Ferraz RR, Baxmann AC, Ferreira LG, Nishiura JL, Siliano PR, Gomes SA, Moreira SR, Heilberg IP.

Urol Res. 2006 Oct;34(5):329-37. Epub 2006 Aug 4.

PMID:
16896690
11.

Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.

Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N.

Urol Res. 2004 Oct;32(5):362-6. Epub 2004 Jun 19.

PMID:
15221244
12.

Effects of an oxalate load on urinary oxalate excretion in calcium stone formers.

de O G Mendonça C, Martini LA, Baxmann AC, Nishiura JL, Cuppari L, Sigulem DM, Heilberg IP.

J Ren Nutr. 2003 Jan;13(1):39-46.

PMID:
12563622
13.

Effect of calcium intake on urinary oxalate excretion in calcium stone-forming patients.

Nishiura JL, Martini LA, Mendonça CO, Schor N, Heilberg IP.

Braz J Med Biol Res. 2002 Jun;35(6):669-75.

Supplemental Content

Loading ...
Support Center